Celldex Therapeutics, Inc. — Director's Dealing 2015

Aug 14, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2015-08-13

Reporting Person: Marucci Anthony S (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-13	Common Stock, par value $0.001 per share	P	5800	$16.8099	Acquired	50028	Direct

Footnotes

F1: Includes 340 shares of common stock acquired under the Company's 2004 Employee Stock Purchase Plan on June 30, 2015.